Log In
BCIQ
Print this Print this
 

Isoplex (Succinylated gelatin)

  Manage Alerts
Collapse Summary General Information
Company Beacon Pharmaceuticals Ltd.
DescriptionSuccinylated gelatin in a balanced electrolyte
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationBlood substitute
Indication DetailsPlasma substitute
Regulatory Designation
PartnerChina Medical System Holdings Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/03/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today